80304 Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in the BHC Act 

(12 U.S.C. 1842(c)). 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than December 18, 2023. 

A. Federal Reserve Bank of Kansas 

City (Jeffrey Imgarten, Assistant Vice 

President) One Memorial Drive, Kansas 

City, Missouri, 64198. Comments can 

also be sent electronically to: 

KCapplicationcomments@kc.frb.org. 

1. WDCO Ventures LLC, Oklahoma 

City, Oklahoma; to become a bank 

holding company by acquiring 26 

percent of the voting shares of Town & 

Country Bancshares, Inc., Edmond, 

Oklahoma, and thereby indirectly 

acquiring voting shares of Prism Bank, 

Guthrie, Oklahoma. 

2. Bern Bancshares, Inc., Bern, 

Kansas; to acquire up to 6.83 percent of 

the voting shares of UBT Bancshares, 

Inc., and thereby indirectly acquire 

voting shares of United Bank & Trust, 

both of Marysville, Kansas. 

B. Federal Reserve Bank of San 

Francisco: (Joseph Cuenco, Assistant 

Vice President, Formations, 

Transactions & Enforcement) 101 

Market Street, San Francisco, California 

94105. Comments can also be sent 

electronically to: 

sf.fisc.comments.applications@

sf.frb.org. 

1. PCB Financial, Inc., Costa Mesa, 

California; to become a bank holding 

company by acquiring Northern 

California Bancorp, Inc., and thereby 

indirectly acquiring Monterey County 

Bank, both of Monterey, California. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2023–25462 Filed 11–16–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Board on Radiation and 

Worker Health, National Institute for 

Occupational Safety and Health 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with regulatory 

provisions, the Centers for Disease 

Control and Prevention (CDC) 

announces a meeting of the Advisory 

Board on Radiation and Worker Health 

(ABRWH or the Advisory Board). This 

meeting is open to the public, with a 

public comment period. The public is 

welcome to submit written comments in 

advance of the meeting, to the contact 

person below. Written comments 

received in advance of the meeting will 

be included in the official record of the 

meeting. The public is also welcomed to 

listen to the meeting by joining the 

teleconference (information below). The 

audio conference line has 150 ports for 

callers. 

DATES: The meeting will be held on 

December 7, 2023 from 11 a.m. to 6 p.m. 

EST. A public comment session will be 

held at 5 p.m. and will conclude at 6 

p.m. or following the final call for 

public comment, whichever comes first. 

Written comments must be received on 

or before November 30, 2023. 

ADDRESSES: You may submit comments 

by mail to: Rashaun Roberts, National 

Institute for Occupational Safety and 

Health, 1090 Tusculum Avenue, MS C– 

24, Cincinnati, Ohio 45226. 

Meeting Information: The USA tollfree dial-in numbers are: +1 669 254 

5252 US (San Jose); +1 646 828 7666 US 

(New York). The Meeting ID is: 160 

6763 3819 and the Passcode is: 

98685439; Web conference by Zoom 

meeting connection: https://

cdc.zoomgov.com/j/16067633819?

pwd=RUdiYXlZZHFKanpJOHZrcGJIb

TlaZz09. 

FOR FURTHER INFORMATION CONTACT: 

Rashaun Roberts, Ph.D., Designated 

Federal Officer, National Institute for 

Occupational Safety and Health, Centers 

for Disease Control and Prevention, 

1090 Tusculum Avenue, Mailstop C–24, 

Cincinnati, Ohio 45226, Telephone 

(513) 533–6800, Toll Free 1(800) CDC– 

INFO, Email: ocas@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines 

which have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule, advice on 

methods of dose reconstruction which 

have also been promulgated by HHS as 

a final rule, advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program, and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort (SEC). In 

December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, 

which subsequently delegated this 

authority to the Centers for Disease 

Control and Prevention (CDC). The 

National Institute for Occupational 

Safety and Health implements this 

responsibility for CDC. 

The charter was issued on August 3, 

2001, renewed at appropriate intervals, 

and rechartered under Executive Order 

13889 on March 22, 2022, and will 

terminate on March 22, 2024. 

Purpose: This Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advising the Secretary 

on whether there is a class of employees 

at any Department of Energy facility 

who were exposed to radiation but for 

whom it is not feasible to estimate their 

radiation dose, and on whether there is 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices 80305 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. 

Matters To Be Considered: The agenda 

will include discussions on the 

following: NIOSH Program Update; 

Department of Labor (DOL) Program 

Update; Department of Energy (DOE) 

Program Update; Special Exposure 

Cohort (SEC) Petitions Update; 

Background and Update on 

Subcommittee for Procedures Review 

Activities; Pinellas Workgroup Update, 

Metals and Control Workgroup Update, 

Dose Reconstruction Review Methods 

Workgroup Update, and a Board Work 

Session. Agenda items are subject to 

change as priorities dictate. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–25460 Filed 11–16–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Injury Prevention 

and Control 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of closed meeting. 

SUMMARY: In accordance with regulatory 

provisions, the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting for the 

Board of Scientific Counselors, National 

Center for Injury Prevention and Control 

(BSC, NCIPC or Board). This meeting is 

partially open to the public. 

DATES: The meeting will be held on 

January 11, 2024. The first session of the 

day will be held from 10 a.m. to 12:05 

p.m., EST (OPEN), and the second 

session will be held from 1 p.m. to 4:30 

p.m., EST (CLOSED). The public 

comment period will be at the end of 

the open session of the meeting, from 

11:45 a.m. to 12:00 p.m., EST. 

ADDRESSES: Webinar, Atlanta, Georgia. 

All participants must register by using 

the following link to attend the open 

session: https://cdc.zoomgov.com/ 

meeting/register/vJItf-igpjopGsXuGU

hsdlIOmRCB2yx509k. 

FOR FURTHER INFORMATION CONTACT: 

Christopher R. Harper, Ph.D., 

Designated Federal Officer, Board of 

Scientific Counselors, National Center 

for Injury Prevention and Control, 

Centers for Disease Control and 

Prevention, 4770 Buford Highway NE, 

Mailstop S–1069, Atlanta, Georgia 

30341. Telephone: (404) 718–8330; 

Email: ncipcbsc@cdc.gov. 

SUPPLEMENTARY INFORMATION: Portions 

of the meeting referenced above will be 

closed to the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5, U.S.C., and 

the Determination of the Director, Office 

of Strategic Business Initiatives, Office 

of the Chief Operating Officer, Centers 

for Disease Control and Prevention, 

pursuant to 5 U.S.C. 1009 (Pub. L. 92– 

463, as amended). 

Purpose: The Board of Scientific 

Counselors, National Center for Injury 

Prevention and Control (BSC, NCIPC or 

Board) will: (1) conduct, encourage, 

cooperate with, and assist other 

appropriate public health authorities, 

scientific institutions, and scientists in 

the conduct of research, investigations, 

experiments, demonstrations, and 

studies relating to the causes and 

strategies related to the prevention of 

injury, overdose, and violence; (2) assist 

States and other entities in preventing 

intentional and unintentional injuries, 

and to promote health and well-being; 

and (3) make recommendations of grants 

and cooperative agreements for research 

and prevention activities related to 

injury, overdose, and violence. The 

BSC, NCIPC makes recommendations 

regarding policies, strategies, objectives, 

and priorities and reviews progress 

toward injury, overdose, and violence 

prevention. The Board also provides 

advice on the appropriate balance of 

intramural and extramural research and 

provides guidance on the needs, 

structure, progress, and performance of 

intramural programs. Further, the Board 

provides guidance on extramural 

scientific program matters. 

Additionally, the Board provides 

second-level scientific and 

programmatic review of applications for 

research grants, cooperative agreements, 

and training grants related to injury, 

overdose, and violence prevention, and 

recommends approval of projects that 

merit further consideration for funding 

support. The Board also provides 

feedback and input on strategic plans, 

resources, and priority publications 

related to injury, overdose, and violence 

prevention. 

Matters To Be Considered: The open 

session of the meeting will include a 

discussion on the updated Intimate 

Partner Violence Research Priorities. 

The closed session of the meeting will 

focus on the secondary peer review of 

extramural research grant applications 

received in response to one (1) Notice of 

Funding Opportunity: RFA–CE–24– 

001—‘‘Grants for Injury Control 

Research Centers.’’ Agenda items are 

subject to change as priorities dictate. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–25456 Filed 11–16–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2023–N–4807] 

General Hospital and Personal Use 

Devices Panel of the Medical Devices 

Advisory Committee; Notice of 

Meeting; Establishment of a Public 

Docket; Request for Comments—506J 

Device List 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; establishment of a 

public docket; request for comments. 

SUMMARY: The Food and Drug 

Administration (FDA) announces a 

forthcoming public advisory committee 

meeting of the General Hospital and 

Personal Use Devices Panel of the 

Medical Devices Advisory Committee 

(the Committee). The general function of 

the Committee is to provide advice and 

recommendations to FDA on regulatory 

issues. The meeting will be open to the 

public. FDA is establishing a docket for 

public comment on this document. 


khammond on DSKJM1Z7X2PROD with NOTICES